ABSTRACT
This study aimed to explore the efficacy and safety of Tangmaikang Granules in the treatment of diabetic peripheral neuropathy(DPN). PubMed, Cochrane Library, EMbase, SinoMed, CNKI, Wanfang and VIP were retrieved for randomized controlled trial(RCT) of Tangmaikang Granules in the treatment of DPN. Cochrane handbook 5.3 was used to evaluate the quality of the inclu-ded studies, and RevMan 5.4.1 and Stata 15.1 were employed to analyze data and test heterogeneity. GRADEpro was used to assess the quality of each outcome index. Clinical effective rate was the major outcome index, while the improvement in numbness of hands and feet, pain of extremities, sluggishness or regression of sensation, sensory conduction velocity(SCV) and motor conduction velocity(MCV) of median nerve and peroneal nerve, fasting blood glucose(FBG), 2 h postprandial blood glucose(2hPBG), and glycated hemoglobin(HbA1c) and incidence of adverse reactions were considered as the minor outcome indexes. A total of 19 RCTs with 1 602 patients were eventually included. The Meta-analysis showed that the improvements in clinical effective rate(RR=1.45, 95%CI[1.32, 1.61], P<0.000 01), pain of extremities(RR=1.70, 95%CI[1.27, 2.27], P=0.000 3), MCV of peroneal nerve(MD=4.08, 95%CI[3.29, 4.86], P<0.000 01) and HbA1c(SMD=-1.23, 95%CI[-1.80,-0.66], P<0.000 1) of Tangmaikang Granules alone or in combination in the experimental group were better than those in the control group. Compared with the conditions in the control group, numbness of hands and feet(RR=1.42, 95%CI[1.12, 1.80], P=0.003), sluggishness or regression of sensation(RR=1.41, 95%CI[1.05, 1.91], P=0.02), SCV of median nerve(MD=4.59, 95%CI[0.92, 8.27], P=0.01), SCV of peroneal nerve(MD=4.68, 95%CI[3.76, 5.60], P<0.000 01) and MCV of median nerve(MD=5.58, 95%CI[4.05, 7.11], P<0.000 01) of Tangmaikang Granules in combination in the experimental group were improved by subgroup analysis. The levels of FBG(MD=-0.57, 95%CI[-1.27, 0.12], P=0.11) and 2hPBG(MD=-0.69, 95%CI[-1.70, 0.33], P=0.18) in the experimental group were similar to those in the control group after treatment with Tangmaikang Granules alone or in combination. There was no difference in the safety(RR=1.28, 95%CI[0.58, 2.82], P=0.54) of Tangmaikang Granules in the treatment of DPN between the experimental group and the control group. Tangmaikang Granules could significantly increase clinical effective rate and nerve conduction velocity as well as improve symptoms of peripheral nerve and blood glucose level, and no serious adverse reactions were identified yet. Further validation was needed in future in large-sample, multicenter, high-quality RCTs.
Subject(s)
Humans , Blood Glucose , Diabetic Neuropathies/drug therapy , Drugs, Chinese Herbal/therapeutic use , Glycated Hemoglobin , Hypesthesia/drug therapy , Multicenter Studies as Topic , Pain/etiology , Treatment Outcome , Peripheral Nervous System Diseases/etiologyABSTRACT
Objective To observe the acarbose combined therapy with sugar pulse phase Ⅰ and phase Ⅱ clinical curative effect of diabetic nephropathy and the effects of oxidative stress on the patients.Methods 188 cases of phase Ⅰ and phase Ⅱ DN patients were selected in hangzhou xixi hospital endocrinology from January 2012 to December 2012,randomly divided into control group and treatment group,94 cases in each groups,the control group given conventional western medicine treatment of diabetic nephropathy,antihypertensive agents using lotensin.Treatment group was treated in the control group on the basis of taking acarbose and sugar pulse tablet.The control group and treatment group a course of eight weeks.Testing for 48 hours patients before and after the urine trace albumin in the urine(UAER)and creatinine ratio(ACR)with urine trace albumin,serum oxide dismutase(SOD),catalase(CAT)and malondialdehyde(MDA).Results The total effective rate was 91.5％in the treatment group,which was significantly higher than that in the control group(68.1％),the total effective rate of the two groups was statistically significant(P<0.05); The levels of UAER and ACR in the treatment group were lower than those in the control group(P<0.05); After treatment,the levels of serum SOD and CAT in the treatment group were higher than those in the control group,the MDA level was lower than that in the control group,the difference was statistically significant(P<0.05); No adverse reactions occurred in the two groups.Conclusion Acarbose combined with Tangmaikang granules in the treatment of DN patients with significant effect,can improve the treatment of diabetic nephropathy,the levels of oxidative stress injury is related to diabetic nephropathy mechanism.
ABSTRACT
Objective To observe the clinical efficacy of Tangmaikang in the treatment of early diabetic nephropathy,and explore the impact of oxidative stress for patients.Methods 94 patients with early diabetic nephropathy were randomly divided into two groups,the control group (n =47) was treated with conventional therapy while the study group (n =47) was given Tangmaikang on the basis of the conventional group,all of the patients was treated for 8 weeks.After the end of treatment,the clinical efficacy and changes in oxidative stress indicators were evaluated.Results The total effective rate of the study group(91.5％) was significantly higher than that of the control group (68.1％),there was statistically significant difference (x2 =57.31,P ＜0.05).The serum superoxide dismutase (SOD) of the study group increased to (81.2 ± 8.9)μU/L,catalase (CAT) increased to (27.3 ± 2.5)μU/L,malondialdehyde(MDA) decreased to (4.9± 0.5)μmol/L,and there were statistically significant differences compared with the control group(t =3.01,2.75,2.14,all P ＜0.05).Conclusion Tangmaikang in the treatment of early diabetic nephropathy has good effect,which plays a renoprotective effect on inhibiting oxidative stress.
ABSTRACT
ObjectiveTo investigate the effects of Tangmaikang on oxidative and carbonyl stress in streptozocin-induced diabetic rat kidneys,and to also explore their reno- protecting mechanisms in diabetic rats.MethodsRats were randomly divided into three sub-groups:normal control (group A),diabetic control (group B) and diabetic with Tangmaikang (group C).Blood glucose,blood lipid,HbAlC,kidney to body weight ratio and urinary protein excretion were measured after 12 weeks.Malonyldialdehyde (MDA)level,superoxide dismutase (SOD) activity,glutathione peroxidase (GSH-Px) activity,total sulfhydryl group and protein carbonyl levels in renal tissue were also determined.ResultsCompared to group A,kidney to body weight ratio,urinary protein excretion,MDA,and protein carbonyl levels in group B were significantly higher,while SOD and GSH-Px activities and total sulfhydryl group level were significantly lower than those in group A.Kidney to body weight ratio,urinary protein excretion,MDA,and protein carbonyl level in group C were significantly lower than those in group B.SOD and GSH-Px activity in group C were higher than those in group B.ConclusionTangmaikang can prevent renal hypertrophy and decrease urinary protein excretion in diabetic rats.The renoprotective effects of this drug may be related to his ability to inhibit oxidative and carbonyl stress.
ABSTRACT
Objective To investigate the effect of Zhonghui Tangmaikang on clinical symptom, blood sugar and lipid of pre-diabetes patients. Method Seventy-two patients of pre-diabetes were divided into 2 groups randomly (36 patients of Zhonghui Tangmaikang group, 36 patients of metformin hydrochloride group), the course of treatment was 12 weeks. The changes of clinical symptoms, FPG, OGTT 2 h PG, TC, TG, LDL-C and HDL-C of the two groups were observed. Result After treatment, the blood sugar of two groups all descended prominently than before (P
ABSTRACT
OBJECTIVE: To study the effects of Tangmaikang granules on blood sugar and sugar tolerance in diabetic mice and on the sugar tolerance of normal rats.METHODS: The diabetic mouse model was induced by alloxan,and the effects of different dosage of Tangmaikang granules on blood sugar and sugar tolerance in experimental diabetic mice and on the sugar tolerance of normal rats were observed.RESULTS: Tangmaikang granules(Medium-dose and high-dose) could downregulate the blood sugar level of experimental diabetic mice and inhibited the glucose-induced increase of the blood sugar level,showing significant differences as compared with the model group(P